Glenview Trust’s Organon & Co OGN Stock Holding History

Glenview Trust’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,357	Closed	-$306K	–	428
2021 Q3	$306K	Sell	9,357 -1,735	-16%	-$55.5K	0.01%	343
2021 Q2	$336K	Buy	+11,092	New	+$365K	0.01%	337

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Glenview Trust's OGN Position: Q4 2021 in Review

Glenview Trust sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 9,357 shares — an estimated $306K sold.

Glenview Trust first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $336K in Q2 2021. 907 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

Glenview Trust reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
Glenview Trust sold 9,357 Organon & Co shares in Q4 2021, an estimated $306K.
Glenview Trust first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
Glenview Trust's Organon & Co position peaked at $336K in Q2 2021.
907 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on Glenview Trust's 13F filing for Q4 2021, filed 10 Feb 2022.